Gyre Therapeutics
GYRE
#5618
Rank
C$1.37 B
Marketcap
$16.00
Share price
4.50%
Change (1 day)
-59.35%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.14

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.02. In 2023 the company made an earnings per share (EPS) of -$2.02 a decrease over its 2022 EPS that were of $0.006258.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.14-107.08%
2023-$2.02-32451.8%
2022$0.006258-90.93%
2021$0.06896